Consent
Far from research being "hindered by restrictions from donors" as you suggest, people are generally willing to donate tissue for research, and even to give open-ended consent to unspecified future applications. This willingness is underpinned by donors' faith in medical research and in their right to protection and confidentiality; the assumption is that their tissue will be used only for 'ethical' investigations.
But problems can arise, for example, over whether consent covers the proposed usage (at present there are many different models of consent, ranging from specific to general), and when and how tissue should be discarded (K. Aalto-Setälä et al. PLoS Biol. 7, e42; 2009 ) .
The answers may not always be obvious, and ethics committees (in collaboration with donors or their representatives) need to take into account the type of tissue involved, as well as the demographics and potential vulnerability of the donor or donor community, in judging the acceptability of a research proposal.
None of this precludes distribution of tissue in the name of scientific progress, nor should it if the wishes of donors are to be respected. However, it does challenge any unqualified presumption among researchers about access to human material; it also calls into question the ethical acceptability of using internationally standardized consent forms, as recommended in your Editorial. Rather, we would argue for international standards to ensure that tissue distribution is not thwarted by ethics committees, accompanied by a plurality of local approaches to obtaining consent.
This strategy would address the problems you outline, while demonstrating respect for moral decisions made by individuals and groups and preserving donors' trust in biological medicine. Call from China for joint nanotech toxicity-testing effort SIR -In response to your News story 'Nanoparticle safety in doubt' about lung damage in Chinese factory workers (Nature 460, 937; 2009), we would like to stress that China has been paying close attention to research into and documentation of the risks of working with nanomaterials.
As in most Western countries, industrial use of nanoscale products has been proliferating in China over the past decade. These are widely used in weaving, dyeing, cosmetics and medicine, for example, as well as in waste-water treatments. The need to develop international standard-analysis protocols to assess nanoparticle toxicities is therefore becoming increasingly urgent.
China is taking measures to address the issues (for a review, see G. Q. Zhou et al. Prog. Biochem. Biophys. 35, 998-1006; 2008 
